Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NOC3L Inhibitors

NOC3L inhibitors are a class of chemical compounds specifically designed to interact with the NOC3L enzyme, which is a protein that plays a crucial role in various cellular processes. The name NOC3L comes from the nomenclature of the protein it targets, where NOC stands for Nucleolar Complex associated, indicating its association with the nucleolus, a small, dense region within the nucleus of the cell where ribosome synthesis occurs, and '3L' typically represents a specific identifier for the protein within a larger family of similar proteins. Inhibition of NOC3L can affect the biological pathways that involve the nucleolus and can influence the regulation of protein synthesis, cell cycle progression, and other nucleolar functions. These inhibitors are typically small molecules that have been developed through an intricate process of medicinal chemistry and high-throughput screening to ensure their efficacy in binding to the NOC3L enzyme. The design and development of NOC3L inhibitors involve understanding the structure and function of the NOC3L enzyme at a molecular level. High-resolution techniques such as X-ray crystallography or NMR spectroscopy may be employed to determine the three-dimensional structure of NOC3L, thus allowing researchers to identify potential binding sites for small molecules. Once these sites are identified, a variety of computational methods, including molecular docking and virtual screening, can be used to predict how different chemical compounds might interact with the enzyme. This is followed by the synthesis and testing of candidate compounds to determine their ability to bind to NOC3L with sufficient affinity and specificity. The chemical characteristics of NOC3L inhibitors, such as their solubility, stability, and reactivity, are optimized through iterative cycles of design and testing, which help in refining their molecular interactions with the target protein. These characteristics are crucial to the inhibitor's performance and are meticulously adjusted to achieve the desired level of interaction with the NOC3L enzyme.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

UCN-01

112953-11-4sc-202376
500 µg
$251.00
10
(1)

UCN-01 is a Staurosporine analog known to inhibit protein kinase C (PKC). As PKC can regulate cell cycle progression, its inhibition can lead to decreased activity of proteins involved in cell cycle control such as NOC3L, which is implicated in ribosomal DNA transcription during the cell cycle.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Roscovitine is a selective inhibitor of cyclin-dependent kinases (CDKs). By inhibiting CDKs, Roscovitine can disrupt the cell cycle, potentially reducing the activity of cell cycle-regulated proteins like NOC3L.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K). PI3K signaling is crucial for many cellular processes, including cell growth and survival. Inhibition of PI3K could indirectly affect NOC3L function as it is involved in the regulation of cell cycle and nucleolar organization.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor that can disrupt protein synthesis and cell growth. As NOC3L is involved in ribosomal DNA transcription, inhibition of mTOR signaling may indirectly decrease NOC3L activity.

Olomoucine

101622-51-9sc-3509
sc-3509A
5 mg
25 mg
$72.00
$274.00
12
(1)

Olomoucine is another CDK inhibitor that can interfere with cell cycle progression. Its action may lead to a reduction in NOC3L activity as NOC3L functions are tied to the cell cycle phases.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a chemical inhibitor of PI3K. By blocking PI3K/AKT signaling, it can lead to cell cycle arrest, potentially decreasing NOC3L activity by limiting the cell cycle-dependent processes in which NOC3L operates.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$68.00
$312.00
2
(1)

Alsterpaullone is a potent inhibitor of CDKs, particularly CDK1 and CDK2. Inhibition of these kinases can lead to cell cycle arrest, thereby indirectly decreasing the functional activity of NOC3L.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-Fluorouracil is an antimetabolite that disrupts DNA synthesis. It indirectly affects proteins like NOC3L, which are involved in nucleolar organization and cell cycle progression, by causing DNA damage and inhibiting DNA replication.

Kenpaullone

142273-20-9sc-200643
sc-200643A
sc-200643B
sc-200643C
1 mg
5 mg
10 mg
25 mg
$61.00
$153.00
$231.00
$505.00
1
(1)

Kenpaullone is a CDK inhibitor capable of blocking cell cycle progression. By doing so, it can indirectly reduce NOC3L activity as its function is cell cycle-dependent.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide causes DNA strand breaks by inhibiting the enzyme topoisomerase II. As NOC3L is involved in ribosomal DNA transcription, disruption of DNA integrity can indirectly inhibit NOC3L activity.